Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Open-label, Non-inferiority Adaptive Platform Randomised Controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Antimalarials for the Treatment of Uncomplicated Malaria in the First Trimester of Pregnancy: Master Protocol

NCT06962319 is registered in ClinicalTrials.gov with Liverpool School of Tropical Medicine as lead sponsor.

NCT NCT06962319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06962319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Open-label, Non-inferiority Adaptive Platform Randomised Controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Antimalarials for the Treatment of Uncomplicated Malaria in the First Trimester of Pregnancy: Master Protocol
Lead sponsor
Liverpool School of Tropical Medicine
Phase
Phase 3
Overall status
Recruiting
Start date
September 30, 2025
Completion date
August 31, 2029
Enrollment
1,510 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

malaria (uncomplicated), malaria, antepartum, malaria, pregnancy